These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9306346)

  • 1. Experience using the Quinton Permcath for haemodialysis in the Irish Republic.
    Boyle MJ; Gawley WF; Hickey DP; Drumm J; Murphy DM; Hanson JS; Glacken P
    Nephrol Dial Transplant; 1997 Sep; 12(9):1934-9. PubMed ID: 9306346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use.
    Schwab SJ; Buller GL; McCann RL; Bollinger RR; Stickel DL
    Am J Kidney Dis; 1988 Feb; 11(2):166-9. PubMed ID: 2963538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infective complications associated with the use of the Quinton 'Permcath' for long-term central vascular access in haemodialysis.
    Dryden MS; Samson A; Ludlam HA; Wing AJ; Phillips I
    J Hosp Infect; 1991 Dec; 19(4):257-62. PubMed ID: 1686038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequacy of haemodialysis with cuffed central-vein catheters.
    Atherikul K; Schwab SJ; Conlon PJ
    Nephrol Dial Transplant; 1998 Mar; 13(3):745-9. PubMed ID: 9550658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do AshSplit haemodialysis catheters provide better flow rates in the long term?
    Keeling AN; O'Dwyer H; Lyon S; O'Kelly P; McGrath FP; Conlon PJ; Lee MJ
    Ren Fail; 2007; 29(6):721-9. PubMed ID: 17763168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the Tesio catheter for hemodialysis in patients with end-stage renal failure: a 2-year prospective study.
    Webb A; Abdalla M; Harden PN; Russell GI
    Clin Nephrol; 2002 Aug; 58(2):128-33. PubMed ID: 12227685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permcath - A Vascular Access for Hemodialysis, Our Experience in Last Two Years.
    Baidya PR; Shrestha K; Deuja ML; Rai A; Shrestha N; Shrestha A; Baidya A
    Kathmandu Univ Med J (KUMJ); 2019 Oct.-Dec.; 17(68):263-266. PubMed ID: 33311033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of permanent hemodialysis catheters: a controlled study.
    Jean G; Charra B; Chazot C; Vanel T; Terrat JC; Hurot JM
    Blood Purif; 2001; 19(4):401-7. PubMed ID: 11574737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PermCath as intravenous access in chronic hemodialysis].
    Mikkelsen S; Gyrtrup HJ; Colstrup H; Nielsen PK
    Ugeskr Laeger; 1992 Jul; 154(30):2073-6. PubMed ID: 1509580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular access surgery: a 2-year study and comparison with the Permcath.
    Mosquera DA; Gibson SP; Goldman MD
    Nephrol Dial Transplant; 1992; 7(11):1111-5. PubMed ID: 1336138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five years experience with the Quinton Permcath for vascular access.
    Gibson SP; Mosquera D
    Nephrol Dial Transplant; 1991; 6(4):269-74. PubMed ID: 1881581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Permcath (Quinton) catheter in uraemic patients in whom the creation of conventional vascular access for haemodialysis is difficult.
    Pourchez T; Morinière P; Fournier A; Pietri J
    Nephron; 1989; 53(4):297-302. PubMed ID: 2601797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Three-and-a-half years' experience with hemodialysis using 37 Permcaths without infection or definitive thrombosis].
    Toulon J; Broyet C; Diab N; Favre JP; Gournier JP; Jurine J; Barral X; Berthoux F
    Nephrologie; 1994; 15(2):95-100. PubMed ID: 7519329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous replacement of a right jugular dialysis catheter via a stenosed superior vena cava.
    Lau KY; Chan JK; Wong WW; Lo SH
    Hong Kong Med J; 2006 Jun; 12(3):235-8. PubMed ID: 16760556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparison of two types of tunneled hemodialysis catheters: the Ash Split versus the PermCath.
    O'Dwyer H; Fotheringham T; O'Kelly P; Doyle S; Haslam P; McGrath F; Conlon P; Lee MJ
    Cardiovasc Intervent Radiol; 2005; 28(1):23-9. PubMed ID: 15602643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central venous access for haemodialysis: prospective evaluation of possible complications.
    de Andrade D; Ferreira V
    J Clin Nurs; 2007 Feb; 16(2):414-8. PubMed ID: 17239078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right atrial catheters: reliable, immediate and durable vascular access for haemodialysis and plasma exchange.
    Francis DM; Goodman DJ; Millar RJ; Walker RG; Becker GJ
    Aust N Z J Surg; 1993 Apr; 63(4):284-8. PubMed ID: 8311814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath.
    Schenk P; Rosenkranz AR; Wölfl G; Hörl WH; Traindl O
    Am J Kidney Dis; 2000 Jan; 35(1):130-6. PubMed ID: 10620554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with the double lumen Silastic catheter for hemoaccess.
    Bour ES; Weaver AS; Yang HC; Gifford RR
    Surg Gynecol Obstet; 1990 Jul; 171(1):33-9. PubMed ID: 2163116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of dual lumen jugular venous catheters as definitive long term access for haemodialysis.
    Blake PG; Huraib S; Wu G; Uldall PR
    Int J Artif Organs; 1990 Jan; 13(1):26-31. PubMed ID: 2394490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.